Thibaut Vaysse

1.8k total citations · 1 hit paper
11 papers, 1.1k citations indexed

About

Thibaut Vaysse is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Thibaut Vaysse has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Thibaut Vaysse's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Thibaut Vaysse is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Thibaut Vaysse collaborates with scholars based in France, Argentina and Israel. Thibaut Vaysse's co-authors include Franck Carbonnel, Christine Mateus, Clélia Coutzac, Émilie Soularue, Nathalie Chaput, Caroline Robert, Michael Collins, Lysiane Marthey, Émilie Lanoy and Lydie Cassard and has published in prestigious journals such as Gastroenterology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Thibaut Vaysse

11 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

2017 972 citations Nathalie Chaput, Patricia Lepage et al. Annals of Oncology profile →

Peers

Thibaut Vaysse

ONCOL

MB

IMMUN

ID

EPIDE

Vahé Asvatourian France

Émilie Soularue France

Clélia Coutzac France

Marine Fidelle France

Tara C. Rubinas United States

Francis J. Huber Germany

Hanyun Ren China

Samantha Wei‐Man Lun Hong Kong

Kenji Gonda Japan

Vincy Eklöf Sweden

Vahé Asvatourian France

Thibaut Vaysse

720 ×0.9

ONCOL

506 ×1.0

MB

225 ×0.9

IMMUN

180 ×0.9

ID

86 ×0.5

EPIDE

Citations per year, relative to Thibaut Vaysse Thibaut Vaysse (= 1×) peers Vahé Asvatourian

Countries citing papers authored by Thibaut Vaysse

Since Specialization

Citations

This map shows the geographic impact of Thibaut Vaysse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thibaut Vaysse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thibaut Vaysse more than expected).

Fields of papers citing papers by Thibaut Vaysse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thibaut Vaysse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thibaut Vaysse. The network helps show where Thibaut Vaysse may publish in the future.

Co-authorship network of co-authors of Thibaut Vaysse

This figure shows the co-authorship network connecting the top 25 collaborators of Thibaut Vaysse. A scholar is included among the top collaborators of Thibaut Vaysse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thibaut Vaysse. Thibaut Vaysse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Vaysse, Thibaut, Matthieu Allez, Bella Ungar, et al.. (2020). Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel disease. Clinics and Research in Hepatology and Gastroenterology. 45(2). 101503–101503. 5 indexed citations

2.

Stefănescu, Carmen, Thibaut Vaysse, David Laharie, et al.. (2019). Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis. Digestive and Liver Disease. 52(3). 268–273. 54 indexed citations

3.

Stefănescu, Carmen, Thibaut Vaysse, David Laharie, et al.. (2019). P715 Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S478–S479. 4 indexed citations

4.

Antoni, Guillemette, Michael Collins, Émilie Soularue, et al.. (2018). Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors. European Journal of Cancer. 106. 106–114. 37 indexed citations

5.

Antoni, Guillemette, Émilie Soularue, Michael Collins, et al.. (2018). 452 - Long-Term Evolution of Gastritis and Enterocolits Induced by Immunological Checkpoint Inhibitors. Gastroenterology. 154(6). S–104. 1 indexed citations

6.

Martineau, Chloé, Bernard Flourié, Pauline Wils, et al.. (2017). Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study. Alimentary Pharmacology & Therapeutics. 46(11-12). 1077–1084. 23 indexed citations

7.

Etchevers, María Josefina, et al.. (2017). P140 Use of vedolizumab in a transplanted liver patient: a case report of the first experience in a liver transplant referral center in Argentina. Journal of Crohn s and Colitis. 11(suppl_1). S147–S147. 3 indexed citations

8.

Chaput, Nathalie, Patricia Lepage, Clélia Coutzac, et al.. (2017). Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Annals of Oncology. 28(6). 1368–1379. 972 indexed citations breakdown →

9.

Grimaud, Jean–Charles, Laurent Peyrin‐Biroulet, Jérôme Filippi, et al.. (2017). Efficacy of Vedolizumab on Extraintestinal Manifestation in Patients with Inflammatory Bowel Diseases: A Post-Hoc Analysis of the Observ-IBD Cohort of the Getaid. Gastroenterology. 152(5). S396–S396. 7 indexed citations

10.

Grimaud, J. C., Laurent Peyrin‐Biroulet, Jérôme Filippi, et al.. (2017). DOP025 Efficacy of vedolizumab on extraintestinal manifestation in patients with inflammatory bowel disease: a post-hoc analysis of the OBSERV-IBD cohort from the GETAID. Journal of Crohn s and Colitis. 11(suppl_1). S42–S42. 9 indexed citations

11.

Vaysse, Thibaut, Isabelle Boytchev, Guillemette Antoni, et al.. (2016). Efficacy and safety of extracorporeal shock wave lithotripsy for chronic pancreatitis. Scandinavian Journal of Gastroenterology. 51(11). 1380–1385. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact